샘플 요청 목록

 카트 문의
시장보고서
상품코드
1564996

세계의 헬리코박터 파일로리 진단 시장

Helicobacter Pylori Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 158 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헬리코박터 파일로리 진단 세계 시장 규모는 2030년까지 9억 6,140만 달러에 달할 것으로 전망

2023년 6억 9,550만 달러로 추정되는 헬리코박터 파일로리 진단 약물 세계 시장은 2030년에는 9억 6,410만 달러에 달할 것으로 예상되며, 분석 기간인 2023-2030년간 4.8%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 병원 최종사용 부문은 4.8%의 연평균 복합 성장률(CAGR)을 기록하여 분석 기간 종료 시점에 4억 3,690만 달러에 도달할 것으로 예상됩니다. 진단센터 최종 사용 분야의 성장률은 분석 기간 동안 CAGR 5.1%로 추정됩니다.

미국 시장은 1억 8,490만 달러, 중국은 CAGR 7.2%로 성장 전망

미국의 헬리코박터 파일로리 진단제 시장은 2023년 1억 8,490만 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 7.2%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년까지 2억 1,000만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.6%와 4.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 2.8%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 헬리코박터 파일로리 진단제 시장 - 주요 동향 및 촉진요인 요약

헬리코박터 파일로리 진단은 위 건강에 필수적?

헬리코박터 파일로리(H. pylori) 진단약은 위장 건강 관리에서 점점 더 중요해지고 있는데, 헬리코박터 파일로리균을 진단하는 것이 왜 이토록 중요한 것일까? 헬리코박터 파일로리균은 위 점막에서 흔히 발견되는 박테리아의 일종으로 위염, 소화성 궤양, 위암 등 다양한 위장 질환의 주요 원인으로 꼽힙니다. 헬리코박터 파일로리균은 위장의 가혹한 산성 환경에서도 살아남을 수 있기 때문에 치료하지 않고 몇 년동안 감염이 지속될 수 있으며, 만성 소화기 질환과 장기적인 건강 합병증을 유발할 수 있습니다. 이러한 증상의 진행을 막기 위해서는 조기에 정확하게 발견하는 것이 필수적입니다.

Helicobacter pylori 감염의 진단은 매우 중요합니다. 왜냐하면 헬리코박터 파일로리균 감염의 증상은 다른 소화기 질환과 유사할 수 있고, 특정 검사를 하지 않고서는 확인하기가 어렵기 때문입니다. 복통, 복부 팽만감, 메스꺼움, 소화불량 등의 증상은 많은 소화기 질환에서 공통적으로 나타나기 때문에 정확한 진단은 헬리코박터 파일로리균 감염과 다른 원인을 감별하는 데 도움이 됩니다. 헬리코박터 파일로리균 검사에는 혈액검사, 대변검사, 호흡검사 등 비침습적인 방법부터 내시경 검사, 생검 등 침습적인 방법까지 다양한 방법이 있습니다. 각 검사의 정확도는 상황에 따라 다르지만, 조기 발견이 심각한 합병증을 예방하는 열쇠가 됩니다. 헬리코박터 파일로리균과 심각한 소화기 질환의 연관성에 대한 인식이 높아짐에 따라, 효과적인 치료와 관리를 위해서는 정확한 진단이 필수적입니다.

기술이 헬리코박터 파일로리균 진단약을 어떻게 향상시켰을까?

기술의 발전으로 헬리코박터 파일로리 진단의 정확성, 속도, 편의성이 크게 향상되어 다양한 임상적 요구에 맞는 다양한 옵션이 제공되고 있습니다. 가장 중요한 기술 혁신 중 하나는 우레아 호흡 검사로, 헬리코박터 파일로리 감염을 감지하는 비침습적 방법으로 가장 널리 사용되고 있습니다. 이 검사는 환자가 우레아 용액을 섭취한 후 호흡 중 탄소 동위원소를 측정하는 방식으로 작동합니다. 헬리코박터 파일로리균이 존재하면 박테리아가 우레아를 분해하여 호흡에서 감지할 수 있는 이산화탄소를 방출합니다. 이 방법은 매우 정확한 결과를 제공하며, 특히 치료 전후에 감염 여부를 확인하는 데 유용하며, 보다 침습적인 검사에 대한 신뢰할 수 있는 대안이 될 수 있습니다.

또 다른 큰 발전은 환자의 대변 샘플에서 헬리코박터 파일로리균의 단백질을 검출하는 대변 항원 검사입니다. 최신 대변 항원 검사는 민감하고 특이적이며, 활동성 감염을 진단할 수 있는 편리하고 비침습적인 방법을 제공합니다. 이러한 검사는 내시경 검사나 호흡 검사를 쉽게 이용할 수 없는 지역에서 특히 유용하며, 저렴한 가격과 접근성으로 인해 임상에서 점점 더 많이 사용되고 있습니다.

생검을 동반한 내시경 검사 등 침습적 검사법도 진단의 정확도가 향상되고 있습니다. PCR(중합효소연쇄반응)과 같은 분자진단법은 일반적으로 사용되는 항생제에 대한 내성을 가진 헬리코박터 파일로리균의 특정 유전자를 검출할 수 있으며, 일반적으로 사용되는 항생제에 대한 내성을 가진 헬리코박터 파일로리균의 특정 유전자를 검출할 수 있어 치료 실패가 증가하는 문제를 해결하는데 도움이 되고 있으며, 약제 내성 균주로 인한 치료 실패 증가라는 문제를 해결하는 데 도움을 주고 있습니다. 이러한 기술의 비약적인 발전은 헬리코박터 파일로리균의 진단을 보다 효과적으로 만들어 보다 빠르고 정확한 검출과 보다 정확한 치료 계획을 가능하게 했습니다.

헬리코박터 파일로리 진단이 공중보건에 필수적인 이유는 무엇인가?

헬리코박터 파일로리균은 널리 퍼져 있고 심각한 위장병에 관여하기 때문에 헬리코박터 파일로리균 진단은 공중 보건에 필수적입니다. 전 세계 인구의 절반 이상이 헬리코박터 파일로리균에 감염된 것으로 추정되지만, 대부분 무증상인 경우가 많습니다. 그러나 증상이 나타나면 만성 위염, 소화성 궤양, 심한 경우 위암 등 심각한 결과를 초래할 수 있습니다. 세계보건기구(WHO)는 헬리코박터 파일로리균과 위암의 강력한 연관성으로 인해 헬리코박터 파일로리균을 1군 발암물질로 분류하고 있으며, 이 치명적인 질병의 발병률을 낮추기 위해서는 조기 발견이 최우선 과제입니다.

Helicobacter pylori에 대한 정기적인 검사는 헬리코박터 파일로리 감염률이 높은 지역이나 의료 접근성이 제한된 지역 등 위장 질환의 위험이 높은 인구 집단에서 특히 중요합니다. 헬리코박터 파일로리 감염을 조기에 진단하고 치료하면 소화성 궤양 발병을 예방하고 위암 발생 위험을 크게 낮춰 장기적인 건강 결과를 개선할 수 있습니다. 이는 위암이 암 관련 사망의 주요 원인 중 하나인 의료 자원이 부족한 국가에서 특히 중요합니다.

임상 현장에서 헬리코박터 파일로리균 진단은 종종 다른 원인으로 오인되는 재발성 위장 증상을 관리하는 데 매우 중요합니다. 만성 소화불량, 위염, 궤양 환자들은 종종 근본적인 세균 감염을 해결하지 않고 대증요법을 받는 경우가 많습니다. 적절한 진단이 이루어지지 않으면, 이러한 환자들은 반복되는 증상으로 고통받거나 시간이 지남에 따라 더 심각한 합병증으로 발전할 수 있습니다. 정확한 검사는 임상의가 감염을 근절하고 재발을 예방하기 위한 표적 치료를 제공함으로써 환자의 예후를 개선하고 의료 비용을 절감하는 데 도움이 됩니다. 위 질환에서 헬리코박터 파일로리균의 역할에 대한 인식이 높아짐에 따라, 진단 약품은 전 세계 위 질환의 부담을 줄이기 위한 공중보건 이니셔티브의 핵심이 되고 있습니다.

헬리코박터 파일로리 진단제 시장의 성장을 가속하는 요인은 무엇인가?

헬리코박터 파일로리 진단제 시장의 성장은 인식 증가, 기술 발전, 위장 질환의 효과적인 관리에 대한 수요 증가가 복합적으로 작용하고 있습니다. 주요 요인 중 하나는 헬리코박터 파일로리 감염과 위암 및 소화성 궤양과 같은 심각한 건강 문제와의 연관성이 점점 더 많이 인식되고 있다는 점입니다. 더 많은 의료 전문가와 공중 보건 기관이 조기 발견과 조기 치료의 중요성을 강조하면서, 신뢰할 수 있고 사용하기 쉬운 진단 도구에 대한 수요가 급증하고 있습니다. 이는 특히 헬리코박터 파일로리균 감염률이 높은 국가에서 두드러지며, 선별검사와 조기 치료를 통해 위암 발생률을 크게 낮출 수 있습니다.

기술의 발전도 시장 성장을 가속하는 주요 요인입니다. 비침습적 우레아 호흡 검사 및 고정밀 대변 항원 검사와 같은 혁신은 헬리코박터 파일로리균 진단을 더욱 친숙하고 편리하게 만들어 의료진이 침습적 절차 없이도 감염을 선별하고 진단할 수 있게 했습니다. 이러한 발전으로 환자들은 외래나 자택에서 쉽게 검사를 받을 수 있게 되어 진단 서비스의 범위가 넓어지고 조기 발견의 가능성이 높아졌습니다. 또한 PCR 검사와 같은 분자진단 방법의 개발로 항생제 내성 헬리코박터 파일로리균의 검출이 가능해져 증가하는 치료 내성 문제를 해결하고 제균 치료의 성공률을 향상시키는 데 도움이 되고 있습니다.

약제 내성 헬리코박터 파일로리균 증가도 고급 진단 약품에 대한 수요를 촉진하고 있습니다. 항생제 내성이 치료를 계속 복잡하게 만들면서 치료를 시작하기 전에 내성 균주를 감지할 수 있는 검사의 필요성이 중요해지고 있습니다. 내성 패턴을 식별함으로써 의사가 가장 효과적인 항생제를 처방할 수 있도록 도와 치료 실패 가능성을 줄이고 내성균의 확산을 방지할 수 있습니다. 이러한 정밀의료로의 전환은 의료 시스템이 항생제 내성과 싸우고 치료 결과를 개선하기 위해 노력하면서 진단 시장 성장을 주도하고 있습니다.

마지막으로, 예방의학에 대한 관심이 높아지면서 헬리코박터 파일로리 진단에 대한 수요가 증가하고 있습니다. 많은 의료기관에서 고위험군을 대상으로 한 선별검사 프로그램을 도입하여 더 심각한 질환으로 발전하기 전에 헬리코박터 파일로리균 감염을 발견하고 치료할 수 있도록 하고 있습니다. 이러한 예방적 접근은 환자의 예후를 개선할 뿐만 아니라, 진행성 위 질환의 치료에 따른 장기적인 의료 비용을 절감할 수 있습니다. 전 세계 헬스케어 트렌드가 조기 발견과 정밀 치료를 우선시하는 가운데, 정확하고 접근하기 쉬운 헬리코박터 파일로리 진단에 대한 수요가 증가하면서 의료 진단 시장의 중요한 성장 분야로 떠오르고 있습니다.

조사 대상 기업 예시(총 12건)

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.10.08

Global Helicobacter Pylori Diagnostics Market to Reach US$964.1 Million by 2030

The global market for Helicobacter Pylori Diagnostics estimated at US$695.5 Million in the year 2023, is expected to reach US$964.1 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by the end of the analysis period. Growth in the Diagnostics Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$184.9 Million While China is Forecast to Grow at 7.2% CAGR

The Helicobacter Pylori Diagnostics market in the U.S. is estimated at US$184.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$210.0 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Helicobacter Pylori Diagnostics Market - Key Trends and Drivers Summarized

Is Helicobacter Pylori Diagnostics Crucial for Stomach Health?

Helicobacter pylori (H. pylori) diagnostics are becoming increasingly important in the management of gastrointestinal health, but what makes diagnosing this bacteria so critical? H. pylori is a type of bacteria commonly found in the stomach lining and is the leading cause of various gastrointestinal disorders, including gastritis, peptic ulcers, and, in some cases, gastric cancer. Because of its ability to survive in the harsh acidic environment of the stomach, H. pylori infections can persist for years without treatment, leading to chronic digestive issues and long-term health complications. Early and accurate detection is essential to preventing the progression of these conditions.

Diagnosing H. pylori infections is crucial because symptoms can often mimic other gastrointestinal problems, making it difficult to identify without specific tests. Symptoms like abdominal pain, bloating, nausea, and indigestion are common in many digestive disorders, so accurate diagnostics help differentiate H. pylori infections from other causes. Tests for H. pylori range from non-invasive methods, such as blood tests, stool tests, and breath tests, to invasive procedures like endoscopy and biopsy. Each test offers varying degrees of accuracy, depending on the situation, but early detection is key in preventing severe complications. As awareness of H. pylori’s link to serious gastrointestinal diseases grows, the demand for precise diagnostics is becoming more critical to effective treatment and management.

How Has Technology Improved Helicobacter Pylori Diagnostics?

Technological advancements have significantly improved the accuracy, speed, and ease of Helicobacter pylori diagnostics, offering a range of options tailored to different clinical needs. One of the most significant innovations is the urea breath test, which has become one of the most widely used non-invasive methods for detecting H. pylori infections. This test works by measuring carbon isotopes in the breath after a patient ingests a urea solution. If H. pylori is present, the bacteria will break down the urea, releasing carbon dioxide that can be detected in the breath. This method provides highly accurate results and is particularly useful for confirming infection before and after treatment, offering a reliable alternative to more invasive testing.

Another major advancement is in stool antigen testing, which detects H. pylori proteins in a patient's stool sample. Modern stool antigen tests are highly sensitive and specific, offering a convenient, non-invasive option for diagnosing active infections. These tests are particularly valuable in areas where endoscopy or breath tests may not be readily available, and they are increasingly used in clinical settings due to their affordability and accessibility.

Invasive testing methods, such as endoscopy with biopsy, have also seen improvements in diagnostic accuracy. Advances in biopsy techniques and molecular testing now allow for the detection of antibiotic resistance in H. pylori strains, guiding more effective treatment strategies. Molecular diagnostics, such as PCR (polymerase chain reaction), can detect specific genes in H. pylori that confer resistance to commonly used antibiotics, helping to address the rising challenge of treatment failure due to drug-resistant strains. These technological breakthroughs have made H. pylori diagnostics more effective, enabling earlier and more precise detection and better-targeted treatment plans.

Why Are Helicobacter Pylori Diagnostics Essential for Public Health?

H. pylori diagnostics are essential for public health due to the bacteria’s widespread prevalence and its role in severe gastrointestinal diseases. It is estimated that over half of the global population is infected with H. pylori, though many remain asymptomatic. However, for those who do develop symptoms, the consequences can be serious, including chronic gastritis, peptic ulcers, and, in extreme cases, gastric cancer. The World Health Organization (WHO) has classified H. pylori as a Group 1 carcinogen due to its strong link to stomach cancer, making early detection a priority for reducing the incidence of this deadly disease.

Routine testing for H. pylori is particularly important in populations at high risk for gastrointestinal disorders, including regions where H. pylori infection rates are high or where access to healthcare is limited. Diagnosing and treating H. pylori infections early can prevent the development of peptic ulcers and significantly reduce the risk of stomach cancer, improving long-term health outcomes. This is especially important in countries with limited resources, where gastric cancer remains one of the leading causes of cancer-related deaths.

In clinical practice, diagnosing H. pylori is crucial for managing recurrent gastrointestinal symptoms that are often misattributed to other causes. Patients with chronic indigestion, gastritis, or ulcers are often treated symptomatically without addressing the underlying bacterial infection. Without proper diagnostics, these patients may continue to suffer from recurring symptoms or develop more serious complications over time. Accurate testing helps clinicians provide targeted treatments that eradicate the infection and prevent relapses, leading to better patient outcomes and reduced healthcare costs. As awareness of H. pylori's role in gastric diseases grows, diagnostics are becoming a cornerstone of public health initiatives aimed at reducing the global burden of stomach disorders.

What Factors Are Driving the Growth of the Helicobacter Pylori Diagnostics Market?

The growth in the Helicobacter pylori diagnostics market is driven by a combination of rising awareness, technological advancements, and increasing demand for effective management of gastrointestinal disorders. One of the primary drivers is the growing recognition of the link between H. pylori infection and serious health issues such as gastric cancer and peptic ulcers. As more healthcare professionals and public health organizations emphasize the importance of early detection and treatment, the demand for reliable, accessible diagnostic tools has surged. This is particularly true in countries with high H. pylori infection rates, where screening and early treatment can significantly reduce the incidence of gastric cancer.

Technological advancements are another major factor propelling market growth. Innovations such as non-invasive urea breath tests and highly accurate stool antigen tests have made H. pylori diagnostics more accessible and convenient, allowing healthcare providers to screen and diagnose infections without the need for invasive procedures. These advancements have made it easier for patients to be tested in outpatient or even home settings, broadening the reach of diagnostic services and increasing the likelihood of early detection. In addition, the development of molecular diagnostics, such as PCR tests, allows for the detection of antibiotic-resistant H. pylori strains, helping to combat the growing problem of treatment resistance and improve the success rates of eradication therapies.

The increasing prevalence of drug-resistant H. pylori strains is also driving demand for more advanced diagnostics. As antibiotic resistance continues to complicate treatment, the need for tests that can detect resistant strains before treatment is initiated has become critical. By identifying resistance patterns, these diagnostics help physicians prescribe the most effective antibiotics, reducing the likelihood of treatment failure and preventing the spread of resistant bacteria. This shift toward precision medicine is driving growth in the diagnostics market as healthcare systems seek to improve treatment outcomes while combating antibiotic resistance.

Lastly, the growing focus on preventive healthcare is pushing the demand for H. pylori diagnostics. Many health systems are adopting screening programs aimed at high-risk populations to detect and treat H. pylori infections before they lead to more severe diseases. This preventive approach not only improves patient outcomes but also reduces the long-term healthcare costs associated with treating advanced gastric diseases. As global healthcare trends continue to prioritize early detection and precision treatment, the demand for accurate and accessible H. pylori diagnostics is set to rise, making it a critical area of growth in the medical diagnostics market.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Helicobacter Pylori Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Helicobacter Pylori Infections Drives Demand for Diagnostic Solutions
    • Growth in Gastrointestinal Disease Screening Expands Addressable Market for H. Pylori Diagnostics
    • Increasing Focus on Early Detection and Treatment of Peptic Ulcers Spurs Adoption of H. Pylori Testing
    • Growth in Use of Urea Breath Tests (UBT) for Non-invasive H. Pylori Detection Drives Adoption
    • Increasing Demand for Point-of-care Testing Solutions Expands Market for H. Pylori Diagnostics
    • Expansion of Diagnostic Laboratories and Healthcare Facilities Boosts Availability of H. Pylori Testing
    • Market Dynamics Driven by Rising Prevalence of Antibiotic-resistant Strains of H. Pylori
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Helicobacter Pylori Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • JAPAN
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • CHINA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • EUROPE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • FRANCE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • GERMANY
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • INDIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • AFRICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제